Belite Bio annual r&d spending
2020
2021
2022
2023
2024
2025
Belite Bio R&D Spending Growth & History (BLTE)
Belite Bio's r&d spending was $45.4M for fiscal 2025.
View full Belite Bio company overviewBelite Bio annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $45.4M | $15.4M | +51.56% |
| 2024 | 2024-12-31 | $29.9M | $5.1M | +20.51% |
| 2023 | 2023-12-31 | $24.8M | $16.0M | +180.12% |
| 2022 | 2022-12-31 | $8.9M | $1.4M | +19.54% |
| 2021 | 2021-12-31 | $7.4M | $3.7M | +101.17% |
| 2020 | 2020-12-31 | $3.7M | — | — |
Belite Bio quarterly r&d spending
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18.2M | $7.2M | +64.84% |
| Q1 2026 | 2026-03-31 | $15.7M | $6.3M | +66.68% |
| Q4 2025 | 2025-12-31 | $14.6M | — | — |
| Q3 2025 | 2025-09-30 | $10.3M | — | — |
| Q2 2025 | 2025-06-30 | $11.0M | — | — |
| Q1 2025 | 2025-03-31 | $9.4M | — | — |
Belite Bio r&d spending trends
Over the last five fiscal years, Belite Bio's r&d spending increased from $3.7M to $45.4M, a change of $41.7M. The latest reported quarter, Q2 2026, shows $18.2M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Belite Bio source filings ↗